Free alerts

LXRX insider buying

Every open-market purchase of Lexicon Pharmaceuticals, Inc. (LXRX) stock by its officers, directors and major shareholders, from SEC Form 4 filings.

Bought, last 12 months$2.72M
Insiders buying (12m)2
Purchases on record4
Last purchase filedFeb 25, 2026

In the last 12 months, 2 insiders of Lexicon Pharmaceuticals, Inc. bought $2.72M of LXRX stock on the open market in 4 reported purchases. The most recent was filed on Feb 25, 2026: Debbane Raymond (Director) bought 100,000 shares at $1.47, worth $147K. The largest purchase on record here is $2M by Artal Group S.A. +8 on Feb 2, 2026.

Get the next LXRX insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All LXRX insider purchases

FiledInsiderValueSharesPriceStakeTrade
Feb 25Debbane RaymondDirector$147K100,000$1.47+6%Feb 23SEC
Feb 23Debbane RaymondDirector$220K150,000$1.47+10%Feb 19SEC
Feb 18Debbane RaymondDirector$353.07K268,497$1.31+19%Feb 13SEC
Feb 4Artal Group S.A. +8Director, 10% Owner$2M1,538,462$1.30newFeb 2SEC